Literature DB >> 28078006

Effects of long non-coding RNA SPRY4-IT1 on osteosarcoma cell biological behavior.

Jin Xu1, Ren Ding1, Yaozeng Xu2.   

Abstract

Recent findings indicate that long noncoding RNAs (lncRNAs) were dysregulated in many kinds of tumors including osteosarcoma (OS). SPRY4-IT1 has been recently revealed as oncogenic regulator in various cancers, while its clinical value and potential function in OS are still unknown. To investigate the role of SPRY4-IT1 in OS, we evaluated the expression SPRY4-IT1 in OS tissues and cell lines, and investigated the effect of SPRY4-IT1 siRNA on cell proliferation, migration and invasion of OS in vitro. Our result showed that SPRY4-IT1 was upregulated in OS tissues. Further experiments revealed that SPRY4-IT1 knockdown significantly inhibited OS cells proliferation by causing G1 arrest and promoting apoptosis. Furthermore, inhibitory effects of SPRY4-IT1 on cell migration and invasion were partly associated with EMT process. In conclusion, these data suggest that SPRY4-IT1 could be an oncogene for OS, and may be served as a candidate target for new therapies in human OS.

Entities:  

Keywords:  EMT; SPRY4-IT1; apoptosis; long noncoding RNA; migration; osteosarcoma; proliferation

Year:  2016        PMID: 28078006      PMCID: PMC5209486     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  22 in total

Review 1.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 2.  Long noncoding RNAs: novel players in colorectal cancer.

Authors:  Dong Han; Meng Wang; Ning Ma; Ya Xu; Yuting Jiang; Xu Gao
Journal:  Cancer Lett       Date:  2015-03-06       Impact factor: 8.679

3.  Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition.

Authors:  Hongjiang Liu; Zhongqiang Lv; Erkun Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.

Authors:  Divya Khaitan; Marcel E Dinger; Joseph Mazar; Joanna Crawford; Martin A Smith; John S Mattick; Ranjan J Perera
Journal:  Cancer Res       Date:  2011-05-10       Impact factor: 12.701

Review 5.  Children's Oncology Group's 2013 blueprint for research: bone tumors.

Authors:  Richard Gorlick; Katherine Janeway; Stephen Lessnick; R Lor Randall; Neyssa Marina
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

6.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

7.  The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.

Authors:  Yongguo Shi; Juan Li; Yangchen Liu; Jie Ding; Yingrui Fan; Yun Tian; Li Wang; Yifan Lian; Keming Wang; Yongqian Shu
Journal:  Mol Cancer       Date:  2015-02-22       Impact factor: 27.401

Review 8.  Gene regulation by the act of long non-coding RNA transcription.

Authors:  Aleksandra E Kornienko; Philipp M Guenzl; Denise P Barlow; Florian M Pauler
Journal:  BMC Biol       Date:  2013-05-30       Impact factor: 7.431

9.  High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.

Authors:  Vanessa Regina Maciel Uzan; André van Helvoort Lengert; Érica Boldrini; Valter Penna; Cristovam Scapulatempo-Neto; Carlos Alberto Scrideli; Alberto Paiva de Moraes Filho; Carlos Eduardo Bezerra Cavalcante; Cleyton Zanardo de Oliveira; Luiz Fernando Lopes; Daniel Onofre Vidal
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

Review 10.  P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.

Authors:  T Velletri; N Xie; Y Wang; Y Huang; Q Yang; X Chen; Q Chen; P Shou; Y Gan; G Cao; G Melino; Y Shi
Journal:  Cell Death Dis       Date:  2016-01-21       Impact factor: 8.469

View more
  9 in total

Review 1.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

Review 2.  The long non-coding RNA SPRY4-IT1: An emerging player in tumorigenesis and osteosarcoma.

Authors:  Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2018-02-27       Impact factor: 6.831

3.  The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma.

Authors:  Xuedong Zhang; Yakui Zhang; Yong Mao; Xinlong Ma
Journal:  Onco Targets Ther       Date:  2018-01-31       Impact factor: 4.147

4.  Comprehensive Characterization of Prognostic Long Noncoding RNAs in Osteosarcoma.

Authors:  Hua Gao; Yuanyuan Guo; Miaomiao Zhang; Zuqiang Yi
Journal:  Biomed Res Int       Date:  2020-08-24       Impact factor: 3.411

Review 5.  A Review on the Role of SPRY4-IT1 in the Carcinogenesis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Mohammad Taheri; Seyedpouzhia Shojaei
Journal:  Front Oncol       Date:  2022-01-13       Impact factor: 6.244

6.  Circular RNA_0001073 (circ_0001073) Suppresses The Progression of Non-Small Cell Lung Cancer via miR-582-3p/RGMB Axis.

Authors:  Xue Fen Jing; Mei Ying Ren; Yong Shun Fan; Yu Hua Fu; Cui Feng Wang
Journal:  Cell J       Date:  2021-11-23       Impact factor: 2.479

7.  Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells.

Authors:  Hongya Guan; Yingwu Mei; Yang Mi; Cheng Li; Xiaoya Sun; Xuefeng Zhao; Jia Liu; Wei Cao; Yuebai Li; Yisheng Wang
Journal:  Onco Targets Ther       Date:  2018-08-14       Impact factor: 4.147

8.  LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity.

Authors:  Hui Yao; Gang Hou; Qi-You Wang; Wen-Bin Xu; Hui-Qing Zhao; Yi-Chun Xu
Journal:  Int J Oncol       Date:  2019-11-13       Impact factor: 5.650

9.  Long non‑coding RNA H19 regulates LASP1 expression in osteosarcoma by competitively binding to miR‑29a‑3p.

Authors:  Hao Jin; Huan Wang; Xin Jin; Wenbo Wang
Journal:  Oncol Rep       Date:  2021-07-30       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.